Market Access Brazil - Health Economics & Regulatory Affairs Congress 2013 is dedicated to various issues of the healthcare industry in Brazil, including health economics strategies and pricing plans, risk-sharing, Public Private Partnerships, Biosimilars and Patient Groups in order to implement a better market access strategy with higher reimbursement.
Executives from Pharma & Biotech Companies involved in Health economics & Outcomes Research, Market Access & Regulatory Affairs, Value Based Pricing, Pricing & Reimbursement, Corporate & External Affairs, Business Development, Medical Information & Education, Patient Advocacy, Specialty and Orphan drugs market, Business Analysis and Patient communication.
